Literature DB >> 26264390

Why Wait Until Our Community Gets Cancer?: Exploring CRC Screening Barriers and Facilitators in the Spanish-Speaking Community in North Carolina.

Christa E Martens1, Trisha M Crutchfield2,3,4, Jane L Laping5, Lexie Perreras5, Daniel S Reuland2,5,4,6, Laura Cubillos5,4, Michael P Pignone2,3,4,6, Stephanie B Wheeler2,3,4,7.   

Abstract

Colorectal cancer (CRC) is a leading cause of death among Hispanics in the United States. Despite the benefits of CRC screening, many Hispanics are not being screened. Using a combined methodology of focus groups and discrete choice experiment (DCE) surveys, the objectives for this research were as follows: (1) to improve understanding of preferences regarding potential CRC screening program characteristics, and (2) to improve understanding of the barriers and facilitators around CRC screening with the Hispanic, immigrant community in North Carolina. Four gender-stratified focus groups were conducted and DCE surveys were administered to 38 Spanish-speaking individuals across four counties in North Carolina. In-depth content analysis was used to examine the focus group data; descriptive analyses and mean attribute importance scores for cost of screening and follow-up care, travel time, and test options were calculated from DCE data. Data analyses showed that this population has a strong interest in CRC screening but experience barriers such as lack of access to resources, cost uncertainty, and stigma. Some of these barriers are unique to their cultural experiences in the United States, such as an expressed lack of tailored CRC information. Based on the DCE, cost variables were more important than testing options or travel time. This study suggests that Hispanics may have a general awareness of and interest in CRC screening, but multiple barriers prevent them from getting screened. Special attention should be given to designing culturally and linguistically appropriate programs to improve access to healthcare resources, insurance, and associated costs among Hispanics.

Entities:  

Keywords:  Colorectal cancer; Discrete choice experiment; Focus groups; Hispanics; Screening

Mesh:

Year:  2016        PMID: 26264390      PMCID: PMC5778446          DOI: 10.1007/s13187-015-0890-4

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  17 in total

1.  A comparison of Latino and Anglo socially desirable responding.

Authors:  Christopher J Hopwood; Claudia G Flato; Suman Ambwani; Beth H Garland; Leslie C Morey
Journal:  J Clin Psychol       Date:  2009-07

Review 2.  Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Jennifer S Lin; Elizabeth Liles; Tracy L Beil; Rongwei Fu
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

3.  Adherence to physician recommendation to colorectal cancer screening colonoscopy among Hispanics.

Authors:  Ghalib Jibara; Lina Jandorf; Monica B Fodera; Katherine N DuHamel
Journal:  J Gen Intern Med       Date:  2011-05-04       Impact factor: 5.128

4.  Colorectal cancer screening: language is a greater barrier for Latino men than Latino women.

Authors:  J A Diaz; M B Roberts; J G Clarke; E M Simmons; R E Goldman; W Rakowski
Journal:  J Immigr Minor Health       Date:  2013-06

5.  Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities.

Authors:  Lina Jandorf; Lauren M Stossel; Julia L Cooperman; Joshua Graff Zivin; Uri Ladabaum; Diana Hall; Linda D Thélémaque; William Redd; Steven H Itzkowitz
Journal:  Cancer       Date:  2012-07-25       Impact factor: 6.860

6.  Testing a Spanish-language colorectal cancer screening decision aid in Latinos with limited English proficiency: results from a pre-post trial and four month follow-up survey.

Authors:  Daniel S Reuland; Linda K Ko; Alicia Fernandez; Laura C Braswell; Michael Pignone
Journal:  BMC Med Inform Decis Mak       Date:  2012-06-12       Impact factor: 2.796

7.  Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina.

Authors:  Michael P Pignone; Trisha M Crutchfield; Paul M Brown; Sarah T Hawley; Jane L Laping; Carmen L Lewis; Kristen Hassmiller Lich; Lisa C Richardson; Florence Kl Tangka; Stephanie B Wheeler
Journal:  BMC Health Serv Res       Date:  2014-11-30       Impact factor: 2.655

8.  Cultural and linguistic adaptation of a multimedia colorectal cancer screening decision aid for Spanish-speaking Latinos.

Authors:  Linda K Ko; Daniel Reuland; Monica Jolles; Rebecca Clay; Michael Pignone
Journal:  J Health Commun       Date:  2013-12-12

Review 9.  Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review.

Authors:  Keith Naylor; James Ward; Blase N Polite
Journal:  J Gen Intern Med       Date:  2012-08       Impact factor: 5.128

10.  Socioeconomic deprivation as a determinant of cancer mortality and the Hispanic paradox in Texas, USA.

Authors:  Billy U Philips; Eric Belasco; Kyriakos S Markides; Gordon Gong
Journal:  Int J Equity Health       Date:  2013-04-15
View more
  13 in total

Review 1.  Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions.

Authors:  Stephanie B Wheeler; Jennifer Leeman; Kristen Hassmiller Lich; Florence K L Tangka; Melinda M Davis; Lisa C Richardson
Journal:  Cancer J       Date:  2018 May/Jun       Impact factor: 3.360

2.  Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of Medicaid and commercial claims data.

Authors:  Melinda M Davis; Stephanie Renfro; Robyn Pham; Kristen Hassmiller Lich; Jackilen Shannon; Gloria D Coronado; Stephanie B Wheeler
Journal:  Prev Med       Date:  2017-05-13       Impact factor: 4.018

3.  Preferences for Surveillance of Barrett's Oesophagus: a Discrete Choice Experiment.

Authors:  Norma B Bulamu; Gang Chen; Tim Bright; Julie Ratcliffe; Adrian Chung; Robert J L Fraser; Björn Törnqvist; David I Watson
Journal:  J Gastrointest Surg       Date:  2018-11-26       Impact factor: 3.452

4.  Assessing Colorectal Cancer Screening Barriers by Two Methods.

Authors:  Mira L Katz; Gregory S Young; Barret J Zimmermann; Cathy M Tatum; Electra D Paskett
Journal:  J Cancer Educ       Date:  2018-06       Impact factor: 2.037

5.  Attributes Used for Cancer Screening Discrete Choice Experiments: A Systematic Review.

Authors:  Rebekah Hall; Antonieta Medina-Lara; Willie Hamilton; Anne E Spencer
Journal:  Patient       Date:  2021-10-21       Impact factor: 3.883

6.  The Cancer Prevention and Control Research Network: Accelerating the implementation of evidence-based cancer prevention and control interventions.

Authors:  Jennifer Leeman; Karen Glanz; Peggy Hannon; Jackilen Shannon
Journal:  Prev Med       Date:  2019-11-11       Impact factor: 4.018

Review 7.  Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013.

Authors:  Carol Mansfield; Florence K L Tangka; Donatus U Ekwueme; Judith Lee Smith; Gery P Guy; Chunyu Li; A Brett Hauber
Journal:  Prev Chronic Dis       Date:  2016-02-25       Impact factor: 2.830

Review 8.  Eliciting vulnerable patients' preferences regarding colorectal cancer screening: a systematic review.

Authors:  Samuel J Lee; Meghan C O'Leary; Karl E Umble; Stephanie B Wheeler
Journal:  Patient Prefer Adherence       Date:  2018-10-31       Impact factor: 2.711

9.  Disentangling Racial, Ethnic, and Socioeconomic Disparities in Treatment for Colorectal Cancer.

Authors:  Chelsea A Obrochta; James D Murphy; Ming-Hsiang Tsou; Caroline A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-06-09       Impact factor: 4.254

10.  What Factors Influence Non-Participation Most in Colorectal Cancer Screening? A Discrete Choice Experiment.

Authors:  Esther W de Bekker-Grob; Bas Donkers; Jorien Veldwijk; Marcel F Jonker; Sylvia Buis; Jan Huisman; Patrick Bindels
Journal:  Patient       Date:  2020-11-05       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.